Publications

Sun, Y., Giavazzi, M., Adda-Decker, M., Barbosa, L., Kouider, S., Bachoud-Levi, A., Jacquemot, C. & Peperkamp, S. (2015). Complex linguistic rules modulate early auditory brain responses. Brain and language, 149, 55-65. doi:10.1016/j.bandl.2015.06.009

Squitieri, F., Gellera, C., Cannella, M., Mariotti, C., Cislaghi, G., Rubinsztein, D., Almqvist, E., Turner, D., Bachoud-Levi, A., Simpson, S., Delatycki, M., Maglione, V., Hayden, M. & Donato, S. (2003). Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain : a journal of neurology, 126(Pt 4), 946-55.

Soulas, T., Cleret de Langavant, L., Monod, V. & Fenelon, G. (2016). The prevalence and characteristics of hallucinations, delusions and minor phenomena in a non-demented population sample aged 60 years and over. . International journal of geriatric psychiatry, 31(12), 1322-1328. doi:10.1002/gps.4437

Simonin, C., Duru, C., Salleron, J., Hincker, P., Charles, P., Delval, A., Youssov, K., Burnouf, S., Azulay, J., Verny, C., Scherer, C., Tranchant, C., Goizet, C., Debruxelles, S., Defebvre, L., Sablonnière, B., Romon-Rousseaux, M., Buée, L., Destée, A., Godefroy, O., Durr, A., Landwehrmeyer, B., Registry Study Of The European Huntington'S Disease, N., Bachoud-Levi, A., Richard, F., Blum, D., Krystkowiak, P. & Huntington French Speaking, N. (2013). Association between caffeine intake and age at onset in Huntington's disease. Neurobiology of disease, 58, 179-82. doi:10.1016/j.nbd.2013.05.013

Shin, M., Jan, C., Jacquard, C., Jarraya, B., Callebert, J., Launay, J., Hantraye, P., Remy, P., Palfi, S. & Brouillet, E. (2011). Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration. Neurobiology of aging, 32(11), 2100-2. doi:10.1016/j.neurobiolaging.2009.11.015

Schramm, C., Bachoud-Levi, A. & Katsahian, S. (2018). Clustering of longitudinal data by using an extended baseline: A new method for treatment efficacy clustering in longitudinal data. Stat Methods Med Res, 27(1), 97-113. doi:10.1177/0962280215621591

Schramm, C., Katsahian, S., Youssov, K., Démonet, J., Krystkowiak, P., Supiot, F., Verny, C., Cleret de Langavant, L. & Bachoud-Levi, A. (2015). How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease. PLoS ONE. doi:10.1371/journal.pone.0145842

Schramm, C., Vial, C., Bachoud-Levi, A. & Katsahian, S. (2015). Clustering of longitudinal data by using an extended baseline: A new method for treatment efficacy clustering in longitudinal data. Statistical methods in medical research, 27(1), 97-113. doi:10.1177/0962280215621591

Sambin, S., Teichmann, M., De Diego Balaguer, R., Giavazzi, M., Sportiche, D., Schlenker, P. & Bachoud-Levi, A. (2012). The role of the striatum in sentence processing: disentangling syntax from working memory in Huntington's disease. Neuropsychologia, 50(11), 2625-35. doi:10.1016/j.neuropsychologia.2012.07.014

Salem, L., Saleh, N., Désaméricq, G., Youssov, K., Dolbeau, G., Cleret de Langavant, L., Bourhis, M., Azulay, J., Krystkowiak, P., Verny, C., Morin, F., Moutereau, S., French Huntington Study, G., Bachoud-Levi, A. & Maison, P. (2016). Insulin-Like Growth Factor-1 but Not Insulin Predicts Cognitive Decline in Huntington's Disease. PloS one, 11(9), e0162890. doi:10.1371/journal.pone.0162890

Salem, L., Saleh, N., Youssov, K., Olivier, A., Charles, P., Scherer, C., Verny, C., Bachoud-Levi, A. & Maison, P. (2014). The most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials. Fundamental & clinical pharmacology, 28(6), 700-10. doi:10.1111/fcp.12077

Saleh, N., Moutereau, S., Azulay, J., Verny, C., Simonin, C., Tranchant, C., El Hawajri, N., Bachoud-Levi, A. & Maison, P. (2010). High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology. doi:10.1212/WNL.0b013e3181e62076

Saleh, N., Moutereau, S., Durr, A., Krystkowiak, P., Azulay, J., Tranchant, C., Broussolle, E., Morin, F., Bachoud-Levi, A. & Maison, P. (2009). Neuroendocrine disturbances in Huntington's disease. PloS one, 4(3), e4962. doi:10.1371/journal.pone.0004962

Salameh , P., Farah, R., Hallit , S., Zeidan , R., Chahine, M., Asmar , R. & Hosseini, H. (2018). Self-reported history of stroke and long-term living conditions near air pollution sources: results of a national epidemiological study in Lebanon. Environ Monit Assess, 190(3), 153. doi:10.1007/s10661-018-6545-2

Rosser, A. & Bachoud-Levi, A. (2012). Clinical trials of neural transplantation in Huntington's disease. Progress in brain research, 200, 345-71. doi:10.1016/B978-0-444-59575-1.00016-8

Robotham, L., Sauter, D., Bachoud-Levi, A. & Trinkler, I. (2011). The impairment of emotion recognition in Huntington's disease extends to positive emotions. Cortex; a journal devoted to the study of the nervous system and behavior, 47(7), 880-4. doi:10.1016/j.cortex.2011.02.014

Rieu, D., Bachoud-Levi, A., Laurent, A., Jurion, E. & Dalla Barba , G. (2006). [French adaptation of the Hopkins Verbal Learning Test] Revue neurologique. doi:10.1016/s0035-3787(06)75069-x

Ribeiro, M., Thobois, S., Lohmann, E., Du Montcel, S., Lesage, S., Pelissolo, A., Dubois, B., Mallet, L., Pollak, P., Agid, Y., Broussolle, E., Brice, A., Remy, P. & French Parkinson'S Disease Genetics Study, G. (2009). A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 50(8), 1244-50. doi:10.2967/jnumed.109.063529

Ribeiro, M., Idbaih, A., Thomas, C., Remy, P., Martin-Duverneuil, N., Samson, Y., Donadieu, J. & Hoang-Xuan, K. (2008). 18F-FDG PET in neurodegenerative Langerhans cell histiocytosis : results and potential interest for an early diagnosis of the disease. Journal of neurology, 255(4), 575-80. doi:10.1007/s00415-008-0751-8

Remy, P. & Samson, Y. (2003). The role of dopamine in cognition: evidence from functional imaging studies. Current opinion in neurology, 16 Suppl 2, S37-41.

Remy, P., Doder, M., Lees, A., Turjanski, N. & Brooks, D. (2005). Decrease of dopamine and noradrenaline innervation in the limbic system of depressed Parkinson’s disease patients. Brain(128 ), 1314-1322

Remy, P., Zilbovicius, M., Degos, J., Bachoud-Levi, A., Rancurel, G., Cesaro, P. & Samson, Y. (1999). Somatosensory cortical activations are suppressed in patients with tactile extinction: a PET study. Neurology. doi:10.1212/wnl.52.3.571

Reinhard, C., Bachoud-Levi, A., Bäumer, T., Bertini, E., Brunelle, A., Buizer, A., Federico, A., Gasser, T., Groeschel, S., Hermanns, S., Klockgether, T., Krägeloh-Mann, I., Landwehrmeyer, G., Leber, I., Macaya, A., Mariotti, C., Meissner, W., Molnar, M. , Nonnekes, J., Ortigoza Escobar, J. , Pérez Dueñas, B., Renna Linton, L., Schöls, L., Schuele, R., Tijssen, M., Vandenberghe, R., Volkmer, A., Wolf, N. & Graessner, H. (2021). The European Reference Network for Rare Neurological Diseases. Frontiers in Neurology, 11. doi:10.3389/fneur.2020.616569

Reilmann, R., McGarry, A. , Grachev, I. , Savola, J. , Borowsky, B., Eyal, E. , Gross, N. , Langbehn, D., Schubert, R. , Wickenberg, A. , Papapetropoulos, S. , Hayden, M. , Squitieri, F., Kieburtz, K. , Landwehrmeyer, G., European Huntington'S Disease, N. & Bachoud-Levi, A. (2019). Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study. The Lancet, Neurology, 18(2), 165-176 . doi:10.1016/S1474-4422(18)30391-0

Pini, L., Sambatoro, F., Youssov, K., Bachoud-Levi, A., Vallesi, A. & Jacquemot, C. (2020). Striatal connectivity in premanifest Huntington disease is differentially affected by disease burden. European Journal of Neurology, 27(11), 2147-2157. doi:10.1111/ene.14423

Pini, L., Jacquemot, C., Cagnin, A., Meneghello, F., Semenza, C., Mantini, D. & Vallesi, A. (2020). Aberrant brain network connectivity in presymptomatic and manifest Huntington's disease: A systematic review. Human Brain Mapping, 1(14), 256-269. doi:10.1002/hbm.24790

Peterson, M., De Gelder, B., Rapcsak, S., Gerhardstein, P. & Bachoud-Levi, A. (2000). Object memory effects on figure assignment: conscious object recognition is not necessary or sufficient. Vision Research, 40, 1549-1567. doi:10.1016/S0042-6989(00)00053-5

Peschanski, M., Bachoud-Levi, A. & Hantraye, P. (2004). Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. Brain : a journal of neurology, 127(Pt 6), 1219-28. doi:10.1093/brain/awh145

Payoux, P., Remy, P., Miloudi, M., Houeto, J., Stadler, C., Bejjani, B., Yelnik, J., Samson, Y., Rascol, O., Agid, Y. & Damier, P. (2009). Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 29(2), 235-43. doi:10.1038/jcbfm.2008.107

Payoux, P., Remy, P., Damier, P., Miloudi, M., Loubinoux, I., Pidoux, B., Gaura, V., Rascol, O., Samson, Y. & Agid, Y. (2004). Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Archives of neurology, 61(8), 1307-13. doi:10.1001/archneur.61.8.1307